A comparative clinical study to evaluate the efficacy and safety of Gasex Extract route tablet in the treatment of dyspepsia. - NI

The Himalaya Drug Company0 个研究点目标入组 60 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Cases with symptoms of dyspepsia like indigestion, gaseousness, flatulence, abdominal distension & belching.
•Hematologic and Biochemical parameters within normal limits.
•Willing to sign inform consent document

•Those with serious cardiovascular, cerebrovascular, respiratory, liver or renal disease or any other disorder.
•The subjects not to have used any drugs, for at least 1 week prior to the study.
•Subjects with a strong history of food or drug allergy of any kind.
•Subjects not to have been on weight reducing diets within 3 months prior to the start of the study.
•No other drugs (including aspirin) to be ingested during the course of the study.
•Patients unwilling to provide informed consent or abide by the requirements of the study

发起方